Female | Male | |||||
---|---|---|---|---|---|---|
Expected | Observed | Ratio observed: expected (95% CI) | Expected | Observed | Ratio observed: expected (95% CI) | |
Opioids | 432 | 659 | 1.5 (1.4–1.6) | 803 | 1194 | 1.5 (1.4–1.6) |
Benzodiazepines | 312 | 554 | 1.8 (1.6–1.9) | 394 | 898 | 2.3 (2.1–2.4) |
Z-hypnotics | 371 | 614 | 1.7 (1.5–1.8) | 442 | 748 | 1.7 (1.6–1.8) |
Gabapentinoids | 31 | 60 | 1.9 (1.4–2.4) | 49 | 93 | 1.9 (1.5–2.3) |
Centrally acting sympathomimetics | 16 | 44 | 2.8 (1.9–3.6) | 67 | 115 | 1.7 (1.4-2.0) |
Selective β2 adrenoceptor agonists | 206 | 249 | 1.2 (1.1–1.4) | 396 | 449 | 1.1 (1.0-1.2) |
Desloratadine | 103 | 91 | 0.9 (0.7–1.1) | 197 | 148 | 0.8 (0.6–0.9) |